TNF and autoimmune disease: The discrepancy has been suggested to be secondary to the cross-species differences between murine and human T cells, the differences in the sensitivity of the experimental conditions or the differing methodologies employed in each laboratory, the early or late stage on immune responses when TNFα stimulation was administered, even whether nTreg or iTreg are the dominant regulatory population in different autoimmune diseases.